A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design

BACKGROUND: Neoadjuvant radiochemotherapy (RCT) is now part of the armamentarium of cancer of the lower and middle rectum. It is recommended in current clinical practice prior to surgical excision if the lesion is classified T3/T4 or N+. Histological complete response, defined by the absence of pers...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lefevre, Jérémie H, Rousseau, Alexandra, Svrcek, Magali, Parc, Yann, Simon, Tabassome, Tiret, Emmanuel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848646/
https://ncbi.nlm.nih.gov/pubmed/24028546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-417
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak